Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events

In the last decade, inhibitors targeting immune checkpoint molecules such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cell death-ligand 1 (PD-L1) brought about a major paradigm shift in cancer treatment. These immune checkpoint inhibitors (ICIs) impro...

Descripción completa

Detalles Bibliográficos
Autor principal: Nakamura, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549005/
https://www.ncbi.nlm.nih.gov/pubmed/31192215
http://dx.doi.org/10.3389/fmed.2019.00119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549005/
https://www.ncbi.nlm.nih.gov/pubmed/31192215
http://dx.doi.org/10.3389/fmed.2019.00119

Ejemplares similares